Wonder if CytoDyns Lawyers are ready to take on AF
Post# of 145338
![Avatar](/images/ProfileImages/584024_1580219148863.jpg)
TWEETED BY Adam Feuerstein
$CYDY leronlimab ph3 study in patients w/ severe Covid19 failed its primary endpoint - improvement in mortality. As with its previous failed study in moderate Covid, the company is spinning the data to cushion the blow of a negative outcome.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)